Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that Chris Xu, PhD, chief executive officer, will present at the BIO CEO & Investor Conference on Monday, February 11, 2019 at 10:30 am ET.
| RANCHO CORDOVA, Calif., /PRNewswire/ --Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that Chris Xu, PhD, chief executive officer, will present at the BIO CEO & Investor Conference on Monday, February 11, 2019 at 10:30 am ET. The conference is being held February 11-12 at the New York Marriott Marquis. Management will also be available for one-on-one meetings with institutional investors who are registered to attend the conference. Institutional investors who would like to attend Cesca’s presentation or meet with management can register through the BIO CEO portal or contact Rx Communications to schedule a meeting. To view the live webcast, please click on the following link: Cesca BIO CEO webcast link. A replay of the webcast will be available one hour after the conclusion of the live event and will expire on Thursday, May 9. The webcast also will be available for viewing on Cesca’s website at: http://investors.cescatherapeutics.com/events-and-presentations/events. About Cesca Therapeutics Inc. Company Contact: Investor Contact:
SOURCE Cesca Therapeutics Inc. | ||
Company Codes: NASDAQ-SMALL:KOOL |
View original content:
